• 1
    Boyd CM, Darer J, Boult C et al. Clinical practice guidelines and quality of care for older patients with multiple comorbid diseases. JAMA 2005;294:716724.
  • 2
    California Healthcare Foundation/American Geriatrics Society Panel on Improving Care for Elders with Diabetes. Guidelines for Improving the Care of the Older Person with Diabetes Mellitus. J Am Geriatr Soc 2003;51(5 Suppl Guidelines):S265S280.
  • 3
    Veterans Health Affairs, Department of Defense. VA/DoD Clinical Practice Guideline for the Management of Diabetes Mellitus. Version 4.0. Release date: August 2010.
  • 4
    Office of Quality and Performance. FY 2011 Q1 Clinical Measures Specification Manual, 2.Veterans Health Administration. October 1, 2010.
  • 5
    Lee DS, Austin PC, Rouleau JL et al. Predicting mortality among patients hospitalized for heart failure: Derivation and validation of a clinical model. JAMA 2003;290:25812587.
  • 6
    Horner MJ, Ries LAG, Krapcho M et al. SEER Cancer Statistics Review, 1975–2006. Bethesda, MD: National Cancer Institute. Available at Accessed July 26, 2011.
  • 7
    Hayward RA. Performance measurement in search of a path. N Engl J Med 2007;346:951952.
  • 8
    Solberg LI, Engebretson KI, Sperl-Hillen JM et al. Are claims data accurate enough to identify patients for performance measures or quality improvement? The case of diabetes, heart disease, and depression. Am J Med Qual 2006;21:238245.
  • 9
    Silveira MJ, Kazanis AS, Shevrin MP. Statins in the last six months of life: A recognizable, life-limiting condition does not decrease their use. J Palliat Med 2008;11:685693.
  • 10
    Braun UK, McCollough LB, Beyth RJ et al. Racial and ethnic differences in the treatment of seriously ill patients: A comparison of African-American, Caucasian and Hispanic veterans. J Natl Med Assoc 2008;100:0411051.
  • 11
    Casarett DJ, Quill TE. “I'm not ready for hospice”: Strategies for timely and effective hospice discussions. Ann Intern Med 2007;146:443449.
  • 12
    Fox E, Landrum-McNiff K, Zhong Z et al. Evaluation of prognostic criteria for determining hospice eligibility in patients with advanced lung, heart, or liver disease. JAMA 1999;282:16381645.
  • 13
    UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 1998;352:837853.
  • 14
    Goddihn PP, Bilo HJ, Feskens EJ et al. Longitudinal study on glycemic control and quality of life in patients with type 2 diabetes mellitus referred for intensified control. Diabet Med 1999;16:2330.
  • 15
    Shorr RI, Franse LV, Resnick He et al. Glycemic control of older adults with type 2 diabetes: Findings from the Third National Health and Nutrition Examination Survey, 1988–94. J Am Geriatr Soc 2000;48:264267.
  • 16
    Office of Quality and Performance. FY 2007, Q3 Technical Manual. VHA Performance Measurement System. Office of Quality and Performance. March 16, 2007.
  • 17
    Petersen LA, Pietz K, Woodard LD et al. Comparison of the predictive validity of diagnosis-based risk adjusters for clinical outcomes. Med Care 2005;43:6167.
  • 18
    Petersen LA, Byrne MM, Daw CN et al. Relationship between clinical conditions and use of Veterans Affairs health care among Medicare-enrolled veterans. Health Serv Res 2010;45:762791.
  • 19
    Rabe-Hesketh S, Skrondal A, Pickles A. GLLAMM Manual, Paper 160. Berkley, CA: University of California, 2004.
  • 20
    McEwen LN, Bilik D, Johnson SL et al. Predictors and impact of intensification of antihyperglycemic therapy in type 2 diabetes. Diabetes Care 2009;32:971976.
  • 21
    Ko DT, Mamdani M, Alter DA. Lipid-lowering therapy with statins in high-risk elderly patients: The treatment-risk paradox. JAMA 2004;291:18641870.
  • 22
    Virani SS, Woodard LD, Chitwood SS et al. Frequency and correlates of treatment intensification for elevated cholesterol levels in patients with cardiovascular disease. Am Heart J 2011;162:725732.
  • 23
    British Medical Association. Quality and outcomes framework guidance: Section 2: Clinical indicators [on-line]. Available at Accessed July 26, 2011.
  • 24
    Doran T, Fullwood C, Reeves D et al. Exclusion of patients from pay-for-performance targets by English physicians. N Engl J Med 2008;359:274284.
  • 25
    McDonald R, Rolan M. Pay for performance in primary care in England and California: Comparison of unintended consequences. Ann Fam Med 2009;7:121127.
  • 26
    Huang ES, Zhang Q, Gandra N et al. The effect of comorbid illness and functional status on the expected benefits of intensive glucose control in older patients with type 2 diabetes: A decision analysis. Ann Intern Med 2008;149:1119.
  • 27
    Bayliss EA, Edwards AE, Steiner JF et al. Processes of care desired by elderly patients with multimorbidities. Fam Pract 2008;25:287293.
  • 28
    Choe HM, Bernstein SJ, Standiford CJ et al. New diabetes HEDIS blood pressure quality measure: Potential for overtreatment. Am J Manag Care 2010;16:1924.
  • 29
    Wegner MS, Solomon DH, Amin A et al. Application of Assessing Care of Vulnerable Elders-3 quality indicators to patients with advanced dementia and poor prognosis. J Am Geriatr Soc 2007;55(Suppl 2):S457S463.
  • 30
    Weiner JS, Roth J. Avoiding iatrogenic harm to patient and family while discussing goals of care near the end of life. J Palliat Med 2006;9:451463.
  • 31
    Larson DG, Tobin DR. End-of-life conversations: Evolving practice and theory. JAMA 2000;284:15731578.
  • 32
    Curtis JR, Patrick DL, Caldwell ES et al. Why don't patients and physicians talk about end-of-life care? Barriers to communication for patients with acquired immunodeficiency syndrome and their primary care clinicians. Arch Intern Med 2000;160:16901696.
  • 33
    Christakis NA, Lamont EB. Extent and determinants of error in doctors’ prognoses in terminally ill patients: Prospective cohort study. BMJ 2000;320:469473.
  • 34
    Executive Summary. American Diabetes Association. Standards of Medical Care in Diabetes—2009. Diabetes Care 2009;32(Suppl 1):S6S12.
  • 35
    Kerr EA, Gerzoff RB, Krein SL et al. Diabetes care quality in the Veterans Affairs Health Care System and commercial managed care: The TRIAD Study. Ann Intern Med 2004;141:272281.
  • 36
    Asch SM, McGlynn EA, Hogan MM et al. Comparison of quality of care for patients in the Veterans Health Administration and patients in a national sample. Ann Intern Med 2004;141:938945.
  • 37
    Walter LC, Davidowtiz NO, Heineken PA et al. Pitfalls of converting practice guidelines into quality measures: Lessons learned from a VA performance measure. JAMA 2004;291:24662470.